Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Marcos Vasquez"'
Autor:
Pedro Berraondo, Ignacio Melero, Jose Medina-Echeverz, Fernando Aranda, Maite Alvarez, Itziar Otano, Shirley Tenesaca, Marcos Vasquez, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Nuria Ardaiz, Celia Gomar, Angela Bella
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Modified vaccinia virus Ankara (MVA) are genetically engineered non-replicating viral vectors. Intratumoral administration of MVA induces a cyclic GMP-AMP synthase-mediated type I interferon (IFN) response and the production of high levels
Externí odkaz:
https://doaj.org/article/134f9c1a54df4aa3bb55a02d549a7554
Autor:
Nuria Ardaiz, Celia Gomar, Marcos Vasquez, Shirley Tenesaca, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Virginia Belsué, Javier Escalada, Ulrich Werner, Norbert Tennagels, Pedro Berraondo
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: Targeting long-lasting insulins to the liver may improve metabolic alterations that are not corrected with current insulin replacement therapies. However, insulin is only able to promote lipogenesis but not to block gluconeogenesis in the
Externí odkaz:
https://doaj.org/article/8e9213d3a8314d028710dd77a2e0ed10
Autor:
Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Angela Bella, Marcos Vasquez, Nuria Ardaiz, Celia Gomar, Leire Arrizabalaga, Sergio Ciordia, Fernando J. Corrales, Fernando Aranda, Pedro Berraondo
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Apolipoprotein A-I mimetic peptides are amphipathic alpha-helix peptides that display similar functions to apolipoprotein A-I. Preclinical and clinical studies have demonstrated the safety and efficacy of apolipoprotein A-I mimetic peptides in multip
Externí odkaz:
https://doaj.org/article/f30515eb133e49479c29e4d0cb9efff2
Autor:
Maria Carmen Ochoa, Luna Minute, Ascensión López, Elisabeth Pérez-Ruiz, Celia Gomar, Marcos Vasquez, Susana Inoges, Iñaki Etxeberria, Inmaculada Rodriguez, Saray Garasa, Jan-Peter Andreas Mayer, Peter Wirtz, Ignacio Melero, Pedro Berraondo
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Enhancement of antibody-dependent cellular cytotoxicity (ADCC) may potentiate the antitumor efficacy of tumor-targeted monoclonal antibodies. Increasing the numbers and antitumor activity of NK cells is a promising strategy to maximize the ADCC of st
Externí odkaz:
https://doaj.org/article/eb4a7b04d61742b58969d7204c422992
Autor:
Pedro Berraondo, Sara Labiano, Luna Minute, Iñaki Etxeberria, Marcos Vasquez, Alvaro Sanchez-Arraez, Alvaro Teijeira, Ignacio Melero
Publikováno v:
OncoImmunology, Vol 6, Iss 5 (2017)
Lessons learned over decades on the use of gene and cell therapies have found clinical applicability in the field of cancer immunotherapy. On December 16th, 2016 a symposium was held in Pamplona (Spain) to analyze and discuss the critical points for
Externí odkaz:
https://doaj.org/article/be99535f192243099148c542643d55d4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emma Nolan, Victoria Louise Bridgeman, Luigi Ombrato, Adam Karoutas, Nicolas Rabas, Celine Angeli Natascha Sewnath, Marcos Vasquez, Felipe Silva Rodrigues, Stuart Horswell, Peter Faull, Rebecca Carter, Ilaria Malanchi
Publikováno v:
Nature Cancer. 3:173-187
Radiotherapy is one of the most effective approaches to achieve tumor control in cancer patients, although healthy tissue injury due to off-target radiation exposure can occur. In this study, we used a model of acute radiation injury to the lung, in
Autor:
Nishtha Sachdeva, Richard Frazin, Ward Manchester, Alessandro Bemporad, Federica Frassati, Federico Nuevo, Marco Romoli, Alberto Marcos Vasquez
Publikováno v:
Solar Physics. 297
Autor:
Fernando Aranda, Marcos Vasquez, Marta Consuegra-Fernández, Aitor Jimenez, Celia Gomar, Noelia Casares, Francisco Lozano, Nuria Ardaiz, Claudia Augusta Di Trani, Juan José Lasarte, Pedro Berraondo, Shirley Tenesaca, Myriam Fernandez-Sendin
Publikováno v:
The Journal of Immunology. 203:696-704
Multiple sclerosis (MS) is a chronic autoimmune disease with no curative treatment. The immune regulatory properties of type I IFNs have led to the approval of IFN-β for the treatment of relapsing-remitting MS. However, there is still an unmet need